Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Free Report) was the target of a large decrease in short interest during the month of January. As of January 31st, there was short interest totalling 5,440,000 shares, a decrease of 5.1% from the January 15th total of 5,730,000 shares. Approximately 10.9% of the shares of the stock are […]
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Free Report) – Equities researchers at Leerink Partnrs upped their FY2024 EPS estimates for shares of Amylyx Pharmaceuticals in a note issued to investors on Monday, January 29th. Leerink Partnrs analyst M. Goodman now expects that the company will post earnings per share of $1.45 for the year, up from […]
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Free Report) was the target of a significant increase in short interest in the month of January. As of January 15th, there was short interest totalling 5,730,000 shares, an increase of 5.3% from the December 31st total of 5,440,000 shares. Approximately 11.5% of the company’s shares are sold short. […]
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Free Report) saw a large growth in short interest in the month of January. As of January 15th, there was short interest totalling 5,730,000 shares, a growth of 5.3% from the December 31st total of 5,440,000 shares. Based on an average trading volume of 1,480,000 shares, the days-to-cover ratio […]
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Free Report)’s stock price gapped up prior to trading on Wednesday . The stock had previously closed at $13.98, but opened at $14.28. Amylyx Pharmaceuticals shares last traded at $14.06, with a volume of 82,167 shares. Wall Street Analysts Forecast Growth AMLX has been the topic of several recent […]